Search

everythinglearnresearchcommunity

for

Search:↓

Enhancing CD8+ T cell function to induce ferroptosis in tumor cells may help treat skin melanoma.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Somatic BHD mutations are rare in Japanese renal tumors.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Both VEPA and ML-Y1 treatments are not effective enough for elderly non-Hodgkin's lymphoma patients.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Ritlecitinib works well and is safe for treating alopecia areata.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Blocking IL-8 can reduce skin rashes from cancer treatment.

A new gene mutation causes vitamin D resistance and rickets, treatable with calcium therapy.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Upadacitinib effectively treats psoriasis and lichen planus together.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Cancer prevention has advanced significantly, with some strategies proving successful.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.